The first goal of the present study was to determine the effect of
tumor necrosis factor-alpha (
TNF-alpha) on the permeability of the blood-brain barrier in vivo. The second goal of this study was to investigate cellular pathways responsible for changes in permeability of the blood-brain barrier in response to
TNF-alpha. We examined the pial microcirculation in rats using intravital fluorescence microscopy. Permeability of the blood-brain barrier was quantitated by calculating the clearance of fluorescent-labeled
dextran (mol. wt=10,000;
FITC-dextran-10K) during superfusion with vehicle,
tumor necrosis factor (
TNF-alpha; 10 ng/ml),
TNF-alpha in the presence of an inhibitor of
soluble guanylate cyclase (ODQ; 1.0 microM), and
TNF-alpha in the presence of an inhibitor of
protein tyrosine kinase (
genistein; 10 microM). During superfusion with vehicle, clearance of FITC-dextran-10K from pial vessels remained relatively constant during the experimental period. In contrast, superfusion with
TNF-alpha markedly increased clearance of FITC-dextran-10K from the cerebral microcirculation. Topical application of ODQ and
genistein, significantly inhibited increases in permeability of the blood-brain barrier to FITC-dextran-10K during application of
TNF-alpha. Thus,
TNF-alpha increases the permeability of the blood-brain barrier to a moderately sized molecule via a mechanism which appears to involve activation of
soluble guanylate cyclase and
protein tyrosine kinase. In light of evidence suggesting that
TNF-alpha production is increased during
cerebrovascular trauma, we suggest that the findings of this study may contribute to our understanding of the pathogenesis of disruption of the blood-brain barrier during
brain trauma and
inflammation.